RMTI
Rockwell Medical Inc
8.00$
-2.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.6% | 96.4% | 94.4% | 83.1% | 89.1% | 83.2% | 89.4% | 72.6% | 75.7% | 55.1% | 62.5% | 66.8% | |
| 67.1% | 35.5% | 20.7% | 14.3% | 43.2% | 26.6% | 62.6% | 27.3% | 21.7% | 17.2% | 26.5% | 18.7% | |
| 87.5% | 80.5% | 69.7% | 56.2% | 63.8% | 58.8% | 75.5% | 46.2% | 46.1% | 21.0% | 36.5% | 43.7% | |
| 4.6% | 5.7% | 7.7% | 10.8% | 14.0% | 9.5% | 5.4% | 12.2% | 13.4% | 20.9% | 14.0% | 14.2% | |
| 4.0% | 9.0% | 14.6% | 13.0% | 7.7% | 8.2% | 5.0% | 8.4% | 12.5% | 11.3% | 9.8% | 6.0% | |
| 1.5% | 1.9% | 3.9% | 14.5% | 8.1% | 6.5% | 7.1% | 21.0% | 18.5% | – | – | – | |
| 0.9% | 1.0% | 1.1% | 1.6% | 1.8% | 2.1% | 1.2% | 1.9% | 2.0% | 1.8% | 1.6% | 1.6% | |
| 0.3% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 20.6% | 17.2% | 16.9% | |
| 29.9% | 29.0% | 36.3% | 44.0% | 48.1% | 54.1% | 56.1% | 94.8% | 69.8% | 59.2% | 45.0% | 35.3% | |
| 10.0% | 9.2% | 12.2% | 15.6% | 25.1% | 27.9% | 16.5% | 43.2% | 37.9% | 31.9% | 23.8% | 16.8% | |
| – | – | – | – | 10.6% | 5.1% | 1.5% | 20.2% | 8.9% | 4.2% | 4.1% | 3.3% | |
| 5.4% | 4.5% | 7.0% | 7.2% | 8.5% | 6.8% | 5.3% | 7.7% | 8.7% | 8.7% | 4.8% | 3.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | 26.9% | 27.1% | 16.2% | 15.9% | 14.3% | 15.4% | |
| 70.1% | 71.0% | 63.7% | 56.0% | 51.9% | 45.9% | 43.9% | 5.2% | 30.2% | 40.8% | 55.0% | 64.7% | |
| -183.8% | -221.5% | -257.8% | -408.8% | -518.3% | -691.6% | -434.0% | -761.9% | -833.6% | -761.3% | -671.7% | -705.2% | |
| 0.4% | 0.5% | 0.6% | 0.8% | 0.9% | 1.2% | 0.9% | 1.8% | 2.1% | 4.5% | 5.2% | 6.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.